CHGG
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trading at a deep discount to historical norms, but value is evaporating as revenue disappears.
- Low P/S ratio
- P/B near 1.0
- Negative Forward P/E
- No Graham Number due to lack of earnings
The business model is facing an existential crisis, likely due to AI disruption.
- Revenue growth -49.40%
- Q/Q Revenue growth -49.36%
A complete reversal of fortune from a growth darling to a distressed asset.
- Strong earnings beats from 2020-2023
- 5Y price change -98.9%
- Recent shift to negative EPS
F-Score indicates very weak financial health; liquidity is insufficient to cover short-term obligations.
- Debt/Equity is moderate
- Piotroski F-Score 2/9
- Current Ratio < 1.0
Not a dividend-paying stock.
- No dividend paid
- No dividend history
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CHGG and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CHGG
Chegg, Inc.
Primary
|
-98.9% | -94.3% | +66.1% | -25.9% | +74.6% | -1.9% |
|
SKIN
The Beauty Health Company
Peer
|
-90.8% | -93.3% | +7.9% | -36.1% | -22.6% | +1.7% |
|
HFFG
HF Foods Group Inc.
Peer
|
-70.7% | -47.9% | -47.4% | -13.3% | +10.6% | +3.0% |
|
BRCC
BRC Inc.
Peer
|
-93.9% | -84.9% | -67.1% | -53.2% | -21.5% | -3.1% |
|
ISPR
Ispire Technology Inc.
Peer
|
-76.8% | -76.2% | -50.8% | -20.4% | -9.8% | +2.3% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Consumer Defensive Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CHGG
Chegg, Inc.
|
BEARISH | $115.15M | - | -66.2% | -27.4% | $1.03 | |
|
SKIN
The Beauty Health Company
|
BEARISH | $116.62M | - | -16.9% | -3.2% | $0.91 | Compare |
|
HFFG
HF Foods Group Inc.
|
BEARISH | $110.86M | - | -17.7% | -3.2% | $2.09 | Compare |
|
BRCC
BRC Inc.
|
BEARISH | $108.91M | - | -47.5% | -2.9% | $0.95 | Compare |
|
ISPR
Ispire Technology Inc.
|
BEARISH | $100.26M | - | -428.6% | -36.6% | $1.75 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | ROSENSWEIG DANIEL L | Chief Executive Officer | Purchase | 100,000 | $56,360 |
| 2025-11-17 | MARTIN MARCELA K | Director | Stock Award | 115,132 | - |
| 2025-11-17 | LONGO DAVID | Chief Financial Officer | Stock Award | 1,000,000 | - |
| 2025-11-17 | SCHLEIN TED | Director | Stock Award | 115,132 | - |
| 2025-11-17 | ROSENSWEIG DANIEL L | Officer and Director | Stock Award | 5,500,000 | - |
| 2025-11-17 | BUDIG RENEE VARNI | Director | Stock Award | 115,132 | - |
| 2025-11-17 | LEVINE MARNE L | Director | Stock Award | 115,132 | - |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning CHGG from our newsroom.